Children's Research Institute

  • CNH-NIAID_2021
    -
    Children's Research Institute

    This annual symposium celebrates the partnership between Children’s National Hospital (CNH) and the National Institute of Allergy and Infectious Diseases (NIAID). Established in 2017, the CNH-NIAID partnership focuses on advancing the health of children with allergic, immunologic, and infectious diseases through collaborative research and education. This year, the Symposium will be held on

  • Urea Cycle Disorders Consortium

    Urea cycle disorders (UCDs) are rare but devastating genetic conditions. In 2003, the Urea Cycle Disorders Consortium (UCDC) became one of the first members of the RDCRN. Since then, UCDC has flourished into an international network of 16 academic centers in the United States, Canada and Europe that provide state-of-the-art care and conduct cutting-edge clinical research. The UCDC is currently

  • Brittle Bone Disorders Consortium (BBD)

    Brittle bone disorders (BBDs), also known as osteogenesis imperfecta, include 13 inherited conditions involving bones that break easily. Brittle bone disorders can cause deformity and chronic pain and lead to premature death. The Brittle Bone Disorders Consortium (BBDC) includes ten medical research sites working to better understand and treat these disorders. The consortium aims to explore the

  • CN-NIAID Virtual Symposium 2020
    -
    Children's Research Institute

    A one day virtual symposium bringing together investigators, researchers, and clinicians from National Institute of Allergy and Infectious Diseases (NIAID) and Children’s National Hospital as well as other interested participants from outside institutions, to discuss the creation, progress, and evolution of this first-of-its-kind collaboration between the NIAID at the National Institutes of Health

  • The National Institutes of Health (NIH) awarded a research team from George Washington (GW), Yale, and Duke Universities $7.8 million to establish a rare disease network for Myasthenia Gravis. The team is led by Henry Kaminiski, MD (GW) and includes Linda Kusner, PhD (GW), Alison Hall, PhD (GW), Jeffrey Guptill, MD (Duke), Richard Nowak, MD (Yale), and Kevin O'Connor, PhD (Yale) as project leaders
  • Children's Research Institute

    Who We Are: We serve as a national level virtual accelerator, providing a platform of experienced regulatory, prototyping, clinical trials design, and commercialization to support CTSA investigators to validate early-stage device concepts addressing an unmet medical need. We source and scout ideas and problems needing technology solutions, and provide funding for promising proof-of concept early

  • -
    Children's Research Institute

    We are excited to invite you to the 2nd Annual Children's National-NIAID Symposium! The Children's National and the National Institute of Allergy and Infectious Diseases (NIAID) partnership focuses on pediatric studies of significant interest to investigators at both institutions. This collaboration is framed and supported through a supplemental award to the Clinical and Translational Science

  • Image

    Children's Research Institute

    The mission of the CTSI-CN is to foster broad collaborative investigation that accelerates discovery and drives dialogue across the bench, bedside, and community continuum.